Skip to content
★ Sign in to follow
HA

Hangzhou AGS MedTech Co., Ltd. Stock: price and insider trades · China

安杰思

CN·Mcap CN¥4.3BHealth Care

Hangzhou AGS MedTech Co., Ltd.: what insiders have been doing

We have very little insider data for Hangzhou AGS MedTech Co., Ltd. so far: the most recent filing dates from 17 December 2024. With so few records, no pattern can be drawn yet. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.

Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€16,105
1 ops. · all time

Who traded when

BuySale
李鹏1 sale

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 6,037 of 26,897 companies
65.6
score / 100
Value
49
Quality
82
FCF yld2.1%
Earn yld5.2%
EV/EBITDA15.7x
ROE8.6%
Gross mgn71%
Net mgn37%
Debt/EBITDA0.1x
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2025

FY ended December 2025 · cache

CN¥53.00
Analyst consensus
1 analysts
·
CN¥84.00Target CN¥84.00(+58%)CN¥84.00
Income statement
RevenueCN¥593.7M
Gross profitCN¥422.1M71% margin
EBITDACN¥275.7M46% margin
Net incomeCN¥221.7M36.1% margin
Valuation
PER (trailing)20.0x
P/Book1.7x
Beta0.45
Balance sheet & cash
Market capCN¥4.3B
Total debtCN¥37.3M
Free Cash FlowCN¥87.7M
Debt / Equity3%
Profitability & ownership
ROE8.6%
ROA4.7%
% insiders66.9%
% institutions7.0%
Last declaration on 17 December 2024
Declarations1 total
  • ▼
    核心技术人员Executives
    123,379 CNY10SSE
    2,016 shares100.0% of flowA股XSHGSSE:173000008359624320

1 of 1 declaration

About Hangzhou AGS MedTech Co., Ltd.

安杰思 is a company operating in the healthcare and pharmaceutical sector, listed on the XSHG market. It focuses on the development and commercialization of innovative pharmaceutical products.

Recent ranked signals in the same sector

Purchases our model currently ranks for the recommendations list.

All recommendations